Markus Ditschkowski

3.4k total citations
45 papers, 1.3k citations indexed

About

Markus Ditschkowski is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Markus Ditschkowski has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 16 papers in Genetics and 15 papers in Immunology. Recurrent topics in Markus Ditschkowski's work include Chronic Myeloid Leukemia Treatments (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Markus Ditschkowski is often cited by papers focused on Chronic Myeloid Leukemia Treatments (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Markus Ditschkowski collaborates with scholars based in Germany, United States and France. Markus Ditschkowski's co-authors include Dietrich W. Beelen, Rudolf Trenschel, Michael Koldehoff, Ahmet Elmaağaclı, Nina K. Steckel, Tanja Gromke, Peter A. Horn, Hellmut Ottinger, Lambros Kordelas and Yael Hegerfeldt and has published in prestigious journals such as Blood, Annals of Surgery and European Journal of Cancer.

In The Last Decade

Markus Ditschkowski

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Ditschkowski Germany	18	748	487	389	360	187	45	1.3k
Anna Paola Iori Italy	20	1.1k 1.5×	300 0.6×	298 0.8×	155 0.4×	118 0.6×	65	1.5k
Emilio Paolo Alessandrino Italy	22	1.1k 1.5×	506 1.0×	179 0.5×	442 1.2×	182 1.0×	60	1.7k
Woo-Sung Min South Korea	21	1.2k 1.5×	221 0.5×	454 1.2×	284 0.8×	228 1.2×	131	1.7k
Jiří Pavlů United Kingdom	19	1.1k 1.5×	649 1.3×	379 1.0×	119 0.3×	216 1.2×	62	1.6k
UW Schaefer Germany	17	894 1.2×	186 0.4×	330 0.8×	248 0.7×	167 0.9×	35	1.3k
Masami Takeuchi Japan	20	425 0.6×	274 0.6×	135 0.3×	327 0.9×	246 1.3×	120	1.4k
P Polchi Italy	21	1.1k 1.5×	932 1.9×	127 0.3×	214 0.6×	145 0.8×	72	1.6k
Marco Marziali Italy	24	363 0.5×	326 0.7×	589 1.5×	242 0.7×	222 1.2×	49	1.5k
J. H. Lipton Canada	15	508 0.7×	242 0.5×	114 0.3×	153 0.4×	62 0.3×	29	808
S. Ferenčík Germany	15	256 0.3×	173 0.4×	646 1.7×	258 0.7×	96 0.5×	40	1.2k

Countries citing papers authored by Markus Ditschkowski

Since Specialization

Citations

This map shows the geographic impact of Markus Ditschkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Ditschkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Ditschkowski more than expected).

Fields of papers citing papers by Markus Ditschkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Ditschkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Ditschkowski. The network helps show where Markus Ditschkowski may publish in the future.

Co-authorship network of co-authors of Markus Ditschkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Ditschkowski. A scholar is included among the top collaborators of Markus Ditschkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Ditschkowski. Markus Ditschkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wagner-Drouet, Eva, Daniel Teschner, Christine Wolschke, et al.. (2021). Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics. 11(2). 312–312. 1 indexed citations

Gagelmann, Nico, Markus Ditschkowski, Swann Bredin, et al.. (2019). Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. Blood. 133(20). 2233–2242. 107 indexed citations

Turki, Amin T., Lambros Kordelas, Rudolf Trenschel, et al.. (2019). Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies. American Journal of Transplantation. 20(3). 677–688. 10 indexed citations

Kordelas, Lambros, Bettina Wagner, Markus Ditschkowski, et al.. (2018). Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease. Bone Marrow Transplantation. 53(9). 1149–1156. 9 indexed citations

Krawczyk, Adalbert, Rudolf Trenschel, Markus Ditschkowski, et al.. (2018). Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR. Journal of Clinical Virology. 99-100. 61–66. 27 indexed citations

Gagelmann, Nico, Markus Ditschkowski, Marie Robin, et al.. (2018). Comprehensive Clinical-Molecular Transplant Risk Model for Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation. Blood. 132(Supplement 1). 689–689. 2 indexed citations

Metzelder, Stephan, Thomas Schroeder, Michael Lübbert, et al.. (2017). Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. European Journal of Cancer. 86. 233–239. 59 indexed citations

Adam, Birgit, Michael Koldehoff, Markus Ditschkowski, et al.. (2016). Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease. Digestive Diseases and Sciences. 61(7). 2019–2026. 6 indexed citations

Elmaağaclı, Ahmet, Markus Ditschkowski, Nina K. Steckel, et al.. (2014). Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD. Bone Marrow Transplantation. 49(6). 800–805. 8 indexed citations

10.

Ditschkowski, Markus, Ahmet Elmaağaclı, Michael Koldehoff, et al.. (2013). Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?. Bone Marrow Transplantation. 48(9). 1224–1229. 33 indexed citations

11.

Ditschkowski, Markus, AH Elmaagacli, Rudolf Trenschel, et al.. (2012). Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis. Haematologica. 97(10). 1574–1581. 38 indexed citations

12.

Elmaağaclı, Ahmet, Nina K. Steckel, Michael Koldehoff, et al.. (2011). Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 118(5). 1402–1412. 248 indexed citations

13.

Elmaağaclı, Ahmet, Nina K. Steckel, Markus Ditschkowski, et al.. (2010). Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors. Bone Marrow Transplantation. 46(5). 702–708. 27 indexed citations

14.

Ditschkowski, Markus, Ahmet Elmaağaclı, Rudolf Trenschel, et al.. (2007). T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica. 92(4). 558–561. 39 indexed citations

15.

Steckel, Nina K., Michael Koldehoff, Markus Ditschkowski, Dietrich W. Beelen, & Ahmet Elmaağaclı. (2007). Use of the Activating Gene Mutation of the Tyrosine Kinase (VAL617Phe) JAK2 as a Minimal Residual Disease Marker in Patients With Myelofibrosis and Myeloid Metaplasia After Allogeneic Stem Cell Transplantation. Transplantation. 83(11). 1518–1520. 22 indexed citations

16.

Koldehoff, Michael, Ahmet Elmaağaclı, Nina K. Steckel, et al.. (2005). Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 7(3-4). 137–145. 4 indexed citations

17.

Koldehoff, Michael, Dietrich W. Beelen, Rudolf Trenschel, et al.. (2004). Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia. Bone Marrow Transplantation. 34(12). 1047–1050. 36 indexed citations

18.

Ditschkowski, Markus, et al.. (2003). Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria. Bone Marrow Transplantation. 32(6). 633–635. 2 indexed citations

19.

Ditschkowski, Markus. (1999). Reduced B Cell HLA-DR Expression and Natural Killer Cell Counts in Patients Prone to Sepsis after Injury. The European Journal of Surgery. 165(12). 1129–1133. 27 indexed citations

20.

Ditschkowski, Markus, E. Kreuzfelder, Vera Rebmann, et al.. (1999). HLA-DR Expression and Soluble HLA-DR Levels in Septic Patients After Trauma. Annals of Surgery. 229(2). 246–254. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact